As of August 30, 2022, ETF Series Solutions - Defiance Next Gen Altered Experience ETF has gone out of business. ETF Series Solutions - Defiance Next Gen Altered Experience ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Defiance ETFs, LLC and Penserra Capital Management, LLC. It invests in the public equity markets of the United States and Canada. The fund invests in the stocks of companies operating in the life sciences companies conducting federally legal medical activities in the psychedelics, medical cannabis, hemp, and cannabidiol industries. It invests in growth and value stocks of companies across diversified market capitalizations. The fund seeks to replicate the performance of BITA Medical Psychedelics, Cannabis, and Ketamine Index, by using full replication technique. ETF Series Solutions - Defiance Next Gen Altered Experience ETF was formed on May 28, 2021 and is domiciled in the United States.